Thailand Chemotherapy Market (2024-2030) | Analysis, Trends, Size, Companies, Outlook, Forecast, Growth, Share, Revenue, Value & Industry

Market Forecast By Drug Class (Alkylating Agents, Mitotic Inhibitors, Antimetabolites, Topoisomerase Inhibitors, Antitumor Antibiotic), By Indication (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, Lymphoma, Leukemia, Ovarian Cancer), By Route of Drug Administration (Intravenous, Oral, Subcutaneous, Intra-Muscular, Intravesicular, Topical, Intraperitoneal, Intraventricular/Intrathecal), By End-Users (Specialty Centers, Hospitals & Clinics) And Competitive Landscape
Product Code: ETC044945 Publication Date: Jul 2023 Updated Date: Jan 2024 Product Type: Report
Publisher: 6Wresearch No. of Pages: 70 No. of Figures: 35 No. of Tables: 5

Thailand Chemotherapy? Market Synopsis

Thailand chemotherapy market is expected to grow at a CAGR of 4.6% in the forecast period 2020-2026 and reach USD XX million by 2026. The increasing prevalence of cancer coupled with the rising demand for effective treatments are driving the growth of Thailand chemotherapy market. Additionally, government initiatives to increase awareness about cancer and its related treatments are providing an impetus to market growth.

Market Drivers

The major drivers boosting the growth of Thailand chemotherapy market include growing geriatric population leading to increased incidence of chronic diseases such as cancer, rising incidence & prevalence rate of cancer, high healthcare expenditure, availability of advanced therapies such as targeted therapy & immunotherapy along with supportive government initiatives encouraging better access to quality treatment solutions for patients suffering from various types of cancers. Moreover, favorable reimbursement policies provided by public and private insurance company also add support in enhancing patient affordability towards cost intensive therapies resulting in improved uptake rates across several regions within Thailand.

Challenges of the Market

One key challenge faced by Thailand Chemotherapy Market is low healthcare spending on prevention measures against lifestyle illnesses like obesity which leads to late diagnosis or misdiagnosis due to lack understanding among populace about risk factors associated with certain cancers that can lead further result into higher costs associated with long periods spent on treatment regimes at later stages when disease has already developed into more advanced forms requiring extensive therapeutic interventions leading towards negative outlook on overall health economics surrounding management options available for those affected by these conditions.Furthermore, certain chemotherapeutic agents have their own set side effects which may hinder patient compliance required during ongoing course making it difficult for providers achieve desired outcomes thus negatively impacting overall drugs utilization patterns across different geographies within country.

Covid-19 Impact on the Market

COVID 19 pandemic has severely impacted global financial markets including Thailand economy.Unprecedented lockdowns imposed across nation due reduced economic activities resulted dramatic slowdown in manufacturing sector thereby contributing negative impacts on GDP figures recorded during same period.Furthermore, disruptions caused supply chain networks made it difficult procure necessary raw materials used produce pharmaceutical preparations consequently affecting drug production operations while sales distribution channels were hampered resulting decline revenues generated by companies operating this space creating significant challenges going forward despite tailwinds created newer opportunities arising out medical equipment industry amid need equip hospitals better manage influx patients needing care facility based services as well home environments where they had been shifted due improving telemedicine capabilities allowing remote consultations.

Key Players of the Market

The key players operating in Thailand chemotherapy market include Pfizer Inc., Merck & Co., GlaxoSmithKline Plc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company (BMS), Eli Lilly and Company, Sanofi SA, Roche Holding AG and AstraZeneca Plc among others. These companies are focusing on expanding their product portfolios with novel therapies that can provide effective results against cancer cases while also reducing side effects associated with traditional chemotherapies like nausea and hair loss. In addition to this they are also investing heavily into research activities aimed at developing more targeted therapies that can improve treatment outcomes by avoiding damage to healthy cells during therapy sessions.

Key Highlights of the Report:

  • Thailand Chemotherapy? Market Outlook
  • Market Size of Thailand Chemotherapy? Market, 2023
  • Forecast of Thailand Chemotherapy? Market, 2030
  • Historical Data and Forecast of Thailand Chemotherapy? Revenues & Volume for the Period 2020-2030
  • Thailand Chemotherapy? Market Trend Evolution
  • Thailand Chemotherapy? Market Drivers and Challenges
  • Thailand Chemotherapy? Price Trends
  • Thailand Chemotherapy? Porter's Five Forces
  • Thailand Chemotherapy? Industry Life Cycle
  • Historical Data and Forecast of Thailand Chemotherapy? Market Revenues & Volume By Drug Class for the Period 2020-2030
  • Historical Data and Forecast of Thailand Chemotherapy? Market Revenues & Volume By Alkylating Agents for the Period 2020-2030
  • Historical Data and Forecast of Thailand Chemotherapy? Market Revenues & Volume By Mitotic Inhibitors for the Period 2020-2030
  • Historical Data and Forecast of Thailand Chemotherapy? Market Revenues & Volume By Antimetabolites for the Period 2020-2030
  • Historical Data and Forecast of Thailand Chemotherapy? Market Revenues & Volume By Topoisomerase Inhibitors for the Period 2020-2030
  • Historical Data and Forecast of Thailand Chemotherapy? Market Revenues & Volume By Antitumor Antibiotic for the Period 2020-2030
  • Historical Data and Forecast of Thailand Chemotherapy? Market Revenues & Volume By Indication for the Period 2020-2030
  • Historical Data and Forecast of Thailand Chemotherapy? Market Revenues & Volume By Lung Cancer for the Period 2020-2030
  • Historical Data and Forecast of Thailand Chemotherapy? Market Revenues & Volume By Breast Cancer for the Period 2020-2030
  • Historical Data and Forecast of Thailand Chemotherapy? Market Revenues & Volume By Colorectal Cancer for the Period 2020-2030
  • Historical Data and Forecast of Thailand Chemotherapy? Market Revenues & Volume By Prostate Cancer for the Period 2020-2030
  • Historical Data and Forecast of Thailand Chemotherapy? Market Revenues & Volume By Stomach Cancer for the Period 2020-2030
  • Historical Data and Forecast of Thailand Chemotherapy? Market Revenues & Volume By Lymphoma for the Period 2020-2030
  • Historical Data and Forecast of Thailand Chemotherapy? Market Revenues & Volume By Leukemia for the Period 2020-2030
  • Historical Data and Forecast of Thailand Chemotherapy? Market Revenues & Volume By Ovarian Cancer for the Period 2020-2030
  • Historical Data and Forecast of Thailand Chemotherapy? Market Revenues & Volume By Route of Drug Administration for the Period 2020-2030
  • Historical Data and Forecast of Thailand Chemotherapy? Market Revenues & Volume By Intravenous for the Period 2020-2030
  • Historical Data and Forecast of Thailand Chemotherapy? Market Revenues & Volume By Oral for the Period 2020-2030
  • Historical Data and Forecast of Thailand Chemotherapy? Market Revenues & Volume By Subcutaneous for the Period 2020-2030
  • Historical Data and Forecast of Thailand Chemotherapy? Market Revenues & Volume By Intra-Muscular for the Period 2020-2030
  • Historical Data and Forecast of Thailand Chemotherapy? Market Revenues & Volume By Intravesicular for the Period 2020-2030
  • Historical Data and Forecast of Thailand Chemotherapy? Market Revenues & Volume By Topical for the Period 2020-2030
  • Historical Data and Forecast of Thailand Chemotherapy? Market Revenues & Volume By Intraperitoneal for the Period 2020-2030
  • Historical Data and Forecast of Thailand Chemotherapy? Market Revenues & Volume By Intraventricular/Intrathecal for the Period 2020-2030
  • Historical Data and Forecast of Thailand Chemotherapy? Market Revenues & Volume By End-Users for the Period 2020-2030
  • Historical Data and Forecast of Thailand Chemotherapy? Market Revenues & Volume By Specialty Centers for the Period 2020-2030
  • Historical Data and Forecast of Thailand Chemotherapy? Market Revenues & Volume By Hospitals & Clinics for the Period 2020-2030
  • Thailand Chemotherapy? Import Export Trade Statistics
  • Market Opportunity Assessment By Drug Class
  • Market Opportunity Assessment By Indication
  • Market Opportunity Assessment By Route of Drug Administration
  • Market Opportunity Assessment By End-Users
  • Thailand Chemotherapy? Top Companies Market Share
  • Thailand Chemotherapy? Competitive Benchmarking By Technical and Operational Parameters
  • Thailand Chemotherapy? Company Profiles
  • Thailand Chemotherapy? Key Strategic Recommendations
Frequently Asked Questions About the Market Study (FAQs):
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Thailand Chemotherapy  Market Overview

3.1 Thailand Country Macro Economic Indicators

3.2 Thailand Chemotherapy  Market Revenues & Volume, 2020 & 2030F

3.3 Thailand Chemotherapy  Market - Industry Life Cycle

3.4 Thailand Chemotherapy  Market - Porter's Five Forces

3.5 Thailand Chemotherapy  Market Revenues & Volume Share, By Drug Class, 2020 & 2030F

3.6 Thailand Chemotherapy  Market Revenues & Volume Share, By Indication, 2020 & 2030F

3.7 Thailand Chemotherapy  Market Revenues & Volume Share, By Route of Drug Administration, 2020 & 2030F

3.8 Thailand Chemotherapy  Market Revenues & Volume Share, By End-Users, 2020 & 2030F

4 Thailand Chemotherapy  Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 Thailand Chemotherapy  Market Trends

6 Thailand Chemotherapy  Market, By Types

6.1 Thailand Chemotherapy  Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 Thailand Chemotherapy  Market Revenues & Volume, By Drug Class, 2020-2030F

6.1.3 Thailand Chemotherapy  Market Revenues & Volume, By Alkylating Agents, 2020-2030F

6.1.4 Thailand Chemotherapy  Market Revenues & Volume, By Mitotic Inhibitors, 2020-2030F

6.1.5 Thailand Chemotherapy  Market Revenues & Volume, By Antimetabolites, 2020-2030F

6.1.6 Thailand Chemotherapy  Market Revenues & Volume, By Topoisomerase Inhibitors, 2020-2030F

6.1.7 Thailand Chemotherapy  Market Revenues & Volume, By Antitumor Antibiotic, 2020-2030F

6.2 Thailand Chemotherapy  Market, By Indication

6.2.1 Overview and Analysis

6.2.2 Thailand Chemotherapy  Market Revenues & Volume, By Lung Cancer, 2020-2030F

6.2.3 Thailand Chemotherapy  Market Revenues & Volume, By Breast Cancer, 2020-2030F

6.2.4 Thailand Chemotherapy  Market Revenues & Volume, By Colorectal Cancer, 2020-2030F

6.2.5 Thailand Chemotherapy  Market Revenues & Volume, By Prostate Cancer, 2020-2030F

6.2.6 Thailand Chemotherapy  Market Revenues & Volume, By Stomach Cancer, 2020-2030F

6.2.7 Thailand Chemotherapy  Market Revenues & Volume, By Lymphoma, 2020-2030F

6.2.8 Thailand Chemotherapy  Market Revenues & Volume, By Ovarian Cancer, 2020-2030F

6.2.9 Thailand Chemotherapy  Market Revenues & Volume, By Ovarian Cancer, 2020-2030F

6.3 Thailand Chemotherapy  Market, By Route of Drug Administration

6.3.1 Overview and Analysis

6.3.2 Thailand Chemotherapy  Market Revenues & Volume, By Intravenous, 2020-2030F

6.3.3 Thailand Chemotherapy  Market Revenues & Volume, By Oral, 2020-2030F

6.3.4 Thailand Chemotherapy  Market Revenues & Volume, By Subcutaneous, 2020-2030F

6.3.5 Thailand Chemotherapy  Market Revenues & Volume, By Intra-Muscular, 2020-2030F

6.3.6 Thailand Chemotherapy  Market Revenues & Volume, By Intravesicular, 2020-2030F

6.3.7 Thailand Chemotherapy  Market Revenues & Volume, By Topical, 2020-2030F

6.3.8 Thailand Chemotherapy  Market Revenues & Volume, By Intraventricular/Intrathecal, 2020-2030F

6.3.9 Thailand Chemotherapy  Market Revenues & Volume, By Intraventricular/Intrathecal, 2020-2030F

6.4 Thailand Chemotherapy  Market, By End-Users

6.4.1 Overview and Analysis

6.4.2 Thailand Chemotherapy  Market Revenues & Volume, By Specialty Centers, 2020-2030F

6.4.3 Thailand Chemotherapy  Market Revenues & Volume, By Hospitals & Clinics, 2020-2030F

7 Thailand Chemotherapy  Market Import-Export Trade Statistics

7.1 Thailand Chemotherapy  Market Export to Major Countries

7.2 Thailand Chemotherapy  Market Imports from Major Countries

8 Thailand Chemotherapy  Market Key Performance Indicators

9 Thailand Chemotherapy  Market - Opportunity Assessment

9.1 Thailand Chemotherapy  Market Opportunity Assessment, By Drug Class, 2020 & 2030F

9.2 Thailand Chemotherapy  Market Opportunity Assessment, By Indication, 2020 & 2030F

9.3 Thailand Chemotherapy  Market Opportunity Assessment, By Route of Drug Administration, 2020 & 2030F

9.4 Thailand Chemotherapy  Market Opportunity Assessment, By End-Users, 2020 & 2030F

10 Thailand Chemotherapy  Market - Competitive Landscape

10.1 Thailand Chemotherapy  Market Revenue Share, By Companies, 2023

10.2 Thailand Chemotherapy  Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All